Lanean...
Neoadjuvant endocrine therapy in breast cancer patients
HIGHLIGHTS: The overall response rate to neoadjuvant endocrine therapy (NET) was 54.55%. The eight patients proposed to tumour's downstage, after 9.71 months of NET, preserved their breast. In the group which achieved response, 10.28 months was the mean time to accomplish it. Even patients who...
Gorde:
| Argitaratua izan da: | Porto Biomed J |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Faculty of Medicine of the University of Porto
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6806912/ https://ncbi.nlm.nih.gov/pubmed/32258615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pbj.2017.03.007 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|